Corelogic (CLGX) Tops Q4 EPS by 4c

Corelogic (NYSE: CLGX) reported Q4 EPS of $0.35, $0.04 better than the analyst estimate of $0.31. Revenue for the quarter came in at $391 million versus the consensus estimate of $367.69 million.

GUIDANCE:

Corelogic sees FY2016 EPS of $2.05-$2.15, versus the consensus of $2.04. Corelogic sees FY2016 revenue of $1.83-1.86 billion, versus the consensus of $1.72 billion.

For earnings history and earnings-related data on Corelogic (CLGX) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
• COPT Defense Properties (CDP) Reports In-Line Q1 EPS; offers guidance